News | Venous Therapies | April 26, 2017

VQI Varicose Vein Registry Yielding Data on Treatment Efficacy

Joint effort of the Society for Vascular Surgery and American Venous Forum was set up to track the outcomes of various treatments for varicose veins

April 26, 2017 — A new Varicose Vein Registry has begun producing useful outcomes information, as reported in the May edition of the Journal of Vascular Surgery: Venous and Lymphatic Disorders. The registry is a joint effort by the Society for Vascular Surgery, the Vascular Quality Initiative and the American Venous Forum. It was launched in January 2015 and was set up to track systematically the outcomes of various treatments for varicose veins, ultimately providing guidance for both consumers and treating physicians.

“The power in the registry resides in the ability to look at a large and varied data set with importantly defined and relevant physician-generated granular endpoints and patient-reported outcomes (PROs),” said Thomas Wakefield, M.D., who, with lead author Andrea Obi, M.D., developed the journal report.

The journal article, “First 10-month results of the Vascular Quality Initiative Varicose Vein Registry,” by a national team of vascular surgeons, examined the early data. The series included 1,406 patients undergoing venous ablations and phlebectomy. Overall, the reported outcomes were excellent, with significantly improved Clinical classification (CEAP) along with “much improved” Patient Reported Outcomes (PRO). Importantly, the complication rates including infection and venous thrombosis were 1 percent or less.

With governmental incentives for quality reporting, there is a pressing need for data in this evolving field, according to the societies. Although the database is in its early stages, they said it is clear it will bear important fruit for both patients and clinicians looking for the best, proven venous treatments available.

To download the complete article, click here.

For information patients may be interested in, click here.

For more information: www.jvsvenous.org

Related Content

Shockwave Announces Collaboration With Abiomed on Physician Training
News | Cath Lab | December 14, 2018
Shockwave Medical announced a new investment and collaboration agreement with Abiomed Inc. As outlined by the agreement...
Sponsored Content | Videos | Cath Lab | October 24, 2018
Michael Flaherty, M.D., discusses a study published in Circulation Research which finds that use of hemodynamic suppo
Philips Showcases Integrated Solutions for Cardiovascular Care at TCT 2018
News | Cath Lab | September 20, 2018
At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing...
Sponsored Content | Videos | Cath Lab | September 19, 2018
William O’Neill, M.D., outlines his recent clinical publication of AMICS patients from the Impella Quality (IQ) datab
A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. DAIC staff photo by Dave Fornell

A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. (right) who is proctoring a fellow in treating CTOs.

Feature | Cath Lab | September 13, 2018 | Artur Kim, Kamran Zamanian
Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and tre
Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
Overlay Init